A newly identified and rare genetic variant slows the growth of mutated blood stem cells, researchers report, and it reduces the risk of leukemia.
Bacterial pathogenesis, evolution, and genomics intersect critically with the ongoing challenge of antimicrobial resistance (AMR), which poses significant ...